The Ombre wellness company recently emerged with a new identity, announcing new leadership, seed funding and a new branding.
The company is now led by CEO Elise Contarsy, an expert in branding and merchandising of consumer products. Contarsy said the redesign gives the brand more leeway to serve more customers in different ways in personalized health.
“We have changed our name and identity to better reflect the business we are building, one that reflects the concept of the quantified self. As consumers evolve and embrace personalized health data, services and products, our brand has grown. We’re not just changing our name; We’re also improving our products and services, including our home testing, gut health reports, and in-app experience. As our name and brand identity change, we will continue with the same DNA analysis process of consumer home test kits ”,Contarsy said NutraIngredients-United States.
New identity, new funds
Ombre raised $ 3 million in a funding round, led by PivotNorth Capital, with participation from Trail Mix Ventures, Shanda Group, Unilever Ventures, Social Starts’ Joyance Partners fund and Unpopular Ventures. This funding round brings the company’s total funds raised to $ 9.5 million.
The new funds will go to Ombre’s evolution, which includes improvements to their products, supply chain and services, such as their home testing, gut health reports, probiotic formulations and their experience in the application.
“Our new probiotic formulations will provide our customers with access to the latest research on probiotic strains to support their wellness goals. Our new proprietary probiotic formulations contain clinically proven strains that target specific symptoms as well as overall health. By modulating the gut biome with research-backed strains, our probiotic design targets microbial imbalances while encouraging the growth of beneficial bacteria that contribute to overall well-being.
Contarsy added that these specific wellness needs target areas such as overall gastrointestinal health, broad spectrum immunity, metabolic health, cardiovascular health, improved energy and support. of mood.
“Each batch is meticulously tested for quality, safety, viability and efficacy. All of our proprietary probiotic blends have a Certificate of Analysis (CoA) for each batch. They are formulated with non-GMO ingredients that are low in fodmap and suitable for vegetarians. While dairy cultures are used to cultivate certain strains, all traces are removed to make the supplement itself vegan. All our probiotics are dairy-free, egg-free, nut-free, gluten-free and soy-free ”,said Contarsy.
According to Research and Markets, the human microbiome market is expected to reach $ 2,921.6 million by 2028, up from $ 718.9 million in 2021.
The future is even brighter for the probiotics market, with Fortune Business Insights forecasting that the global probiotics market will reach over $ 94 billion by 2027 while posting a CAGR of 7.9% between 2020 and 2027. The current probiotic market is valued at 61 billion.
“Ombre has excellent unit economics with the ability to sell test candidates to probiotic subscribers,” sHelps Tim Connors, founder of PivotNorth Capital. “We see a significant advantage as the company is relaunched with a new brand, supply chain improvements and demonstrated consumer demand for probiotic products.”